{"id":19212,"date":"2025-05-18T17:35:56","date_gmt":"2025-05-18T16:35:56","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=19212"},"modified":"2025-08-10T16:58:02","modified_gmt":"2025-08-10T15:58:02","slug":"cannabis-vaping-and-drug-trends-among-youth-in-australia-2014-2024-a-growing-concern","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2025\/05\/cannabis-vaping-and-drug-trends-among-youth-in-australia-2014-2024-a-growing-concern\/","title":{"rendered":"Cannabis Vaping and Drug Trends Among Youth in Australia (2014\u20132024): A Growing Concern"},"content":{"rendered":"<div class=\"g-grid\">\n<div class=\"g-block size-100\">\n<div class=\"g-content\">\n<div class=\"platform-content\">\n<div class=\"module-druginfo-heading moduletable \">\n<div id=\"mod-custom691\" class=\"mod-custom custom\">\n<h2><\/h2>\n<p><img decoding=\"async\" src=\"https:\/\/d1r9bdsrv6vekg.cloudfront.net\/images\/images-links\/image003.gif\" alt=\"image003\" \/><\/p>\n<p>Published by NIH\/NIDA 14 May 2025<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-19213\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2025\/05\/Vaping-1.jpg\" alt=\"\" width=\"573\" height=\"332\" \/><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"g-grid\">\n<div class=\"g-block size-100\">\n<div class=\"g-content\">\n<div class=\"platform-content container\">\n<div class=\"row\">\n<div class=\"col\">\n<div class=\"com-content-article item-page\">\n<div class=\"com-content-article__body\">\n<p>Cannabis vaping is making headlines worldwide, often promoted as a \u201csafer\u201d alternative to smoking. Meanwhile, Drug Trends data from Australia reveal that non-prescribed cannabis use remains high among people who regularly use drugs. But are wider permission models and positive propaganda about cannabis leading to greater engagement, especially among those most at risk? This article dives into Australian data from the Ecstasy and Related Drugs Reporting System (EDRS) and Illicit Drugs Reporting System (IDRS), exploring what\u2019s really happening with cannabis products, vaping, and why honest health education is more critical than ever.<\/p>\n<p><strong>Cannabis Vaping and Drug Trends in Australia (2014\u20132024): What the Data Tells Us<\/strong><\/p>\n<p>Cannabis vaping, once an afterthought, now claims a growing share of the global market. Many believe vaping to be less harmful, with marketers highlighting vaping\u2019s lack of smoke and alleged respiratory benefits. However, recent Drug Trends research in Australia challenges some of these assumptions and uncovers troubling patterns.<\/p>\n<p><strong><em>The Rise of Electronic Vaping Products<\/em><\/strong><\/p>\n<p>Electronic vaping products started as oversized gadgets in the late 1990s. Initially intended to vaporise dried cannabis herb, they eventually shrank, morphing into today\u2019s sleek e-cigarettes. While vaping nicotine products has become mainstream, cannabis vaping is following close behind, spurred in part by changes to medicinal and recreational cannabis laws overseas.<\/p>\n<p>A North American review found a seven-fold increase in monthly cannabis vaping among adolescents, with notable shifts from dried herb to potent cannabis oils. However, the situation in Australia is different, shaped by stricter regulations and unique market conditions.<\/p>\n<p><strong><em>Drug Trends in Non-Prescribed Cannabis Use<\/em><\/strong><\/p>\n<p>Australia\u2019s EDRS and IDRS surveys collect real-world data on non-prescribed cannabis and cannabinoid-related products. Between 2014 and 2024, most participants in both systems reported using cannabis recently, with rates as high as 90% in the EDRS and 74% in the IDRS.<\/p>\n<p>Hydroponic and Bush Cannabis Still Dominate<\/p>\n<ul>\n<li><strong>Hydroponic cannabis<\/strong>\u00a0was the most popular, with usage rates ranging from 63%\u201383% among EDRS respondents, and a remarkable 88%\u201394% for IDRS participants.<\/li>\n<li><strong>Bush cannabis<\/strong>\u00a0also stayed common, with 51%\u201377% (EDRS) and 37%\u201354% (IDRS) reporting use.<\/li>\n<li>Other cannabis products, such as THC extracts and commercially-prepared edibles, have appeared in recent years, showing increased product diversity\u2014but are far less popular than traditional forms.<\/li>\n<\/ul>\n<p><strong><em>Cannabis Vaping Emerges, But Smoking Prevails<\/em><\/strong><\/p>\n<p>Despite media attention around cannabis vaping, the majority of Australians captured in these studies still smoke cannabis. From 2014 to 2024:<\/p>\n<ul>\n<li>Smoking remained the dominant route of administration (ROA) in both groups.<\/li>\n<li>Cannabis vaping (inhaling\/vaporising) trended upward, but stayed a minority choice. Vaporising among EDRS participants increased from 12% to 25%, and from 2% to 9% for IDRS.<\/li>\n<\/ul>\n<p>Notably, few users chose vaping as their only method. Most combined it with smoking, suggesting the rise in vaping hasn\u2019t replaced traditional habits.<\/p>\n<p><strong><em>Concerns About Cannabis Vaping and Permission Models<\/em><\/strong><\/p>\n<p>The Problem with Changing Perceptions<\/p>\n<p>There is growing concern that permission models and positive messaging around cannabis use (whether through legislation or social media) may downplay its risks. Vaping, in particular, is surrounded by claims of being a \u201csafer\u201d alternative to smoking. While it\u2019s true that vaping doesn\u2019t involve combustion and may expose users to fewer toxic chemicals, it\u2019s not risk-free.<\/p>\n<p><strong>Key Issues Include<\/strong>:<\/p>\n<ul>\n<li><strong>Potency extremes<\/strong>: Some vape oils and extracts reach THC concentrations of 70\u201390%, far higher than the average 10%\u201320% in cannabis herb. Highly potent products carry greater risks for dependence, anxiety, and psychosis.<\/li>\n<li><strong>Unknown health risks<\/strong>: The long-term effects of inhaling cannabis vapour, especially from unregulated or home-made devices, are not fully understood.<\/li>\n<li><strong>Discreet use and normalisation<\/strong>: Portability and subtlety make vaping easier to hide, particularly from parents and teachers. For some users, this can enable more frequent use or uptake at a younger age.<\/li>\n<li><strong>Unhealthy dual use<\/strong>: Most vapers continue smoking, increasing overall exposure to both methods. (for complete research\u00a0<strong>WRD News<\/strong>)<\/li>\n<\/ul>\n<p><strong><span style=\"font-size: 14pt;\">Source: https:\/\/www.dalgarnoinstitute.org.au\/index.php\/resources\/drug-information-sheets\/2672-cannabis-vaping-and-drug-trends-among-youth-in-australia-2014-2024-a-growing-concern?<\/span><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Published by NIH\/NIDA 14 May 2025 &nbsp; Cannabis vaping is making headlines worldwide, often promoted as a \u201csafer\u201d alternative to smoking. Meanwhile, Drug Trends data from Australia reveal that non-prescribed cannabis use remains high among people who regularly use drugs. But are wider permission models and positive propaganda about cannabis leading to greater engagement, especially [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73,15,30,31,129,68,65,33,64,34,37,80,132,124,120,43,59,135,86,40,74,92,130,134,61],"tags":[],"class_list":["post-19212","post","type-post","status-publish","format-standard","hentry","category-addiction","category-australia","category-cannabis-marijuana","category-cocaine","category-culture","category-drug-use-various-effects","category-drugs-and-accidents","category-ecstasy","category-health","category-heroin-methadone","category-hiv-injecting-drug-users","category-ketamine","category-khat","category-kratom","category-mental-health","category-methamphetamine-ghb-hallucinogens-oxycodone","category-nicotine","category-opioids","category-prescription-drugs","category-prevention-research","category-solvent-abuse","category-synthetics","category-tobacco-smoking","category-vaping","category-youth"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/19212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=19212"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/19212\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=19212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=19212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=19212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}